vs
德康医疗（DXCM）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Rackspace Technology, Inc.的1.8倍（$1.3B vs $682.8M），德康医疗净利率更高（21.2% vs -4.8%，领先26.0%），德康医疗同比增速更快（21.6% vs -0.4%），过去两年德康医疗的营收复合增速更高（12.0% vs -0.6%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
DXCM vs RXT — 直观对比
营收规模更大
DXCM
是对方的1.8倍
$682.8M
营收增速更快
DXCM
高出22.0%
-0.4%
净利率更高
DXCM
高出26.0%
-4.8%
两年增速更快
DXCM
近两年复合增速
-0.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $682.8M |
| 净利润 | $267.3M | $-32.7M |
| 毛利率 | 62.9% | 17.6% |
| 营业利润率 | 25.6% | -0.5% |
| 净利率 | 21.2% | -4.8% |
| 营收同比 | 21.6% | -0.4% |
| 净利润同比 | 153.6% | 41.6% |
| 每股收益（稀释后） | $0.67 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMRXT
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $682.8M | ||
| Q3 25 | $1.2B | $671.2M | ||
| Q2 25 | $1.2B | $666.3M | ||
| Q1 25 | $1.0B | $665.4M | ||
| Q4 24 | $1.1B | $685.6M | ||
| Q3 24 | $994.2M | $675.8M | ||
| Q2 24 | $1.0B | $684.9M |
净利润DXCMRXT
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $-32.7M | ||
| Q3 25 | $283.8M | $-67.1M | ||
| Q2 25 | $179.8M | $-54.5M | ||
| Q1 25 | $105.4M | $-71.5M | ||
| Q4 24 | $151.7M | $-56.0M | ||
| Q3 24 | $134.6M | $-186.6M | ||
| Q2 24 | $143.5M | $25.0M |
毛利率DXCMRXT
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 17.6% | ||
| Q3 25 | 60.5% | 19.4% | ||
| Q2 25 | 59.5% | 19.4% | ||
| Q1 25 | 56.9% | 19.1% | ||
| Q4 24 | 58.9% | 19.2% | ||
| Q3 24 | 59.7% | 20.3% | ||
| Q2 24 | 62.4% | 19.2% |
营业利润率DXCMRXT
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | -0.5% | ||
| Q3 25 | 20.1% | -5.1% | ||
| Q2 25 | 18.4% | -3.8% | ||
| Q1 25 | 12.9% | -5.8% | ||
| Q4 24 | 17.0% | -4.2% | ||
| Q3 24 | 15.3% | -25.7% | ||
| Q2 24 | 15.7% | -7.9% |
净利率DXCMRXT
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | -4.8% | ||
| Q3 25 | 23.5% | -10.0% | ||
| Q2 25 | 15.5% | -8.2% | ||
| Q1 25 | 10.2% | -10.7% | ||
| Q4 24 | 13.6% | -8.2% | ||
| Q3 24 | 13.5% | -27.6% | ||
| Q2 24 | 14.3% | 3.7% |
每股收益（稀释后）DXCMRXT
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $-0.13 | ||
| Q3 25 | $0.70 | $-0.28 | ||
| Q2 25 | $0.45 | $-0.23 | ||
| Q1 25 | $0.27 | $-0.31 | ||
| Q4 24 | $0.37 | $-0.20 | ||
| Q3 24 | $0.34 | $-0.82 | ||
| Q2 24 | $0.35 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $2.7B | $-1.2B |
| 总资产 | $6.3B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMRXT
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $105.8M | ||
| Q3 25 | $1.8B | $99.5M | ||
| Q2 25 | $1.2B | $103.9M | ||
| Q1 25 | $904.9M | $128.0M | ||
| Q4 24 | $606.1M | $144.0M | ||
| Q3 24 | $621.2M | $157.1M | ||
| Q2 24 | $939.2M | $190.2M |
总债务DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B |
股东权益DXCMRXT
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $-1.2B | ||
| Q3 25 | $2.7B | $-1.2B | ||
| Q2 25 | $2.6B | $-1.1B | ||
| Q1 25 | $2.3B | $-1.1B | ||
| Q4 24 | $2.1B | $-1.0B | ||
| Q3 24 | $2.0B | $-949.7M | ||
| Q2 24 | $2.4B | $-756.2M |
总资产DXCMRXT
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $2.8B | ||
| Q3 25 | $7.5B | $2.8B | ||
| Q2 25 | $7.3B | $2.9B | ||
| Q1 25 | $6.8B | $3.0B | ||
| Q4 24 | $6.5B | $3.1B | ||
| Q3 24 | $6.4B | $3.1B | ||
| Q2 24 | $6.8B | $3.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $59.7M |
| 自由现金流经营现金流 - 资本支出 | — | $56.0M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $90.6M |
8季度趋势，按日历期对齐
经营现金流DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $59.7M | ||
| Q3 25 | $659.9M | $70.7M | ||
| Q2 25 | $303.0M | $8.4M | ||
| Q1 25 | $183.8M | $12.6M | ||
| Q4 24 | $301.4M | $54.3M | ||
| Q3 24 | $199.5M | $51.8M | ||
| Q2 24 | $279.4M | $24.1M |
自由现金流DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $56.0M | ||
| Q3 25 | $579.4M | $42.7M | ||
| Q2 25 | $208.9M | $-12.4M | ||
| Q1 25 | $96.8M | $4.3M | ||
| Q4 24 | $176.8M | $34.4M | ||
| Q3 24 | $88.3M | $27.3M | ||
| Q2 24 | $213.3M | $-14.5M |
自由现金流率DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 8.2% | ||
| Q3 25 | 47.9% | 6.4% | ||
| Q2 25 | 18.1% | -1.9% | ||
| Q1 25 | 9.3% | 0.6% | ||
| Q4 24 | 15.9% | 5.0% | ||
| Q3 24 | 8.9% | 4.0% | ||
| Q2 24 | 21.2% | -2.1% |
资本支出强度DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.5% | ||
| Q3 25 | 6.7% | 4.2% | ||
| Q2 25 | 8.1% | 3.1% | ||
| Q1 25 | 8.4% | 1.2% | ||
| Q4 24 | 11.2% | 2.9% | ||
| Q3 24 | 11.2% | 3.6% | ||
| Q2 24 | 6.6% | 5.6% |
现金转化率DXCMRXT
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | 0.96× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
